LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 240

Search options

  1. Book ; Conference proceedings: Satellite Symposium on: Asthma Management - the Future?

    Yernault, J. C.

    Florence, Italy - Villa Vittoria, Congress Center, September 27, 1993. [Satellite symposium to the European Respiratory Society annual congress]

    (European respiratory review ; 4,21)

    1994  

    Title variant Asthma management - the future?
    Institution European Respiratory Society
    Event/congress Satellite Symposium on Asthma Management the Future? (1993, Florenz)
    Author's details ed. by J. C. Yernault
    Series title European respiratory review ; 4,21
    Collection
    Keywords Asthma / drug therapy / congresses
    Language English
    Size S. 280 - 311 : graph. Darst.
    Publisher Munksgaard u.a.
    Publishing place Copenhagen u.a.
    Publishing country Denmark
    Document type Book ; Conference proceedings
    HBZ-ID HT006267257
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Book ; Conference proceedings: Therapeutic approach to respiratory tract inflammatory diseases

    Yernault, J. C.

    a new insight ; (fenspiride - Pneumorel 80mg) ; satellite symposium of the SEPCR, Lausanne (Switzerland), 28 June 1989

    (European respiratory review ; 1,2)

    1991  

    Institution European Society for Clinical Respiratory Physiology
    Author's details ed.: J. C. Yernault
    Series title European respiratory review ; 1,2
    Keywords Respiratory Tract Diseases / drug therapy / congresses ; Inflammation / drug therapy / congresses ; Spiro Compounds / therapeutic use / congresses
    Language English
    Size S. [63] - 126 : graph. Darst.
    Publisher Munksgaard
    Publishing place Copenhagen
    Publishing country Denmark
    Document type Book ; Conference proceedings
    HBZ-ID HT003934469
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Book ; Conference proceedings: A new therapeutic approach in alpha-1-antitrypsin deficiency

    Yernault, J. C.

    proceedings of a workshop held in Copenhagen, November 1988

    (The European respiratory journal : Supplement ; 9)

    1990  

    Author's details ed. by J. C. Yernault
    Series title The European respiratory journal : Supplement ; 9
    The European respiratory journal
    The European respiratory journal ; Supplement
    Collection The European respiratory journal
    The European respiratory journal ; Supplement
    Keywords Alpha 1-Antitrypsin / deficiency / congresses ; Atmungsinsuffizienz ; Chronische Krankheit ; Prävention ; Therapie ; Lungenkrankheit ; Rehabilitation
    Subject Ateminsuffizienz ; Respiratorische Insuffizienz ; Verhütung ; Vorbeugung ; Prophylaxe ; Vorsorge ; Rehabilitierung ; Lungenerkrankung ; Medizinische Behandlung ; Behandlung ; Krankenbehandlung ; Krankheit ; Chronisches Leiden ; Chronische Krankheiten
    Language English
    Size 52s S. : Ill., graph. Darst.
    Publisher Munksgaard
    Publishing place Copenhagen
    Publishing country Denmark
    Document type Book ; Conference proceedings
    HBZ-ID HT003510339
    ISBN 87-16-14825-8 ; 978-87-16-14825-4
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  4. Book ; Conference proceedings: Present concepts in the adult respiratory distress syndrome (ARDS)

    Yernault, J. C.

    proceedings of a symposium held in Lausanne, Switzerland June 1989

    (The European respiratory journal : Supplement ; 11)

    1990  

    Title variant Present role of sleep study in lung disease
    Author's details ed. by J. C. Yernault
    Series title The European respiratory journal : Supplement ; 11
    The European respiratory journal
    The European respiratory journal ; Supplement
    Collection The European respiratory journal
    The European respiratory journal ; Supplement
    Keywords Sleep Apnea Syndromes / congresses ; Lung Diseases / complications / congresses ; Respiratory Distress Syndrome / congresses ; ARDS
    Subject Acute respiratory distress syndrome ; Adult respiratory distress syndrome ; Schocklunge ; Akute respiratorische Insuffizienz ; Atemnotsyndrom ; Akutes Lungenversagen
    Language English
    Size S. 483s-549s. : Ill., graph. Darst.
    Publisher Munksgaard
    Publishing place Copenhagen
    Publishing country Denmark
    Document type Book ; Conference proceedings
    Note Falsche ISBN in d. Vorlage: 870-16-14885-1 ; Enth. außerdem: Present role of sleep study in lung disease
    HBZ-ID HT003678462
    ISBN 87-16-14885-1 ; 978-87-16-14885-8
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article: Dyspnoea in the elderly: a clinical approach to diagnosis.

    Yernault, J C

    Drugs & aging

    2001  Volume 18, Issue 3, Page(s) 177–187

    Abstract: This review briefly overviews the pathophysiology of dyspnoea and then focuses on discussion of the most frequent causes of chronic and acute dyspnoea in the elderly. The most common causes of dyspnoea in the elderly include heart failure, chronic ... ...

    Abstract This review briefly overviews the pathophysiology of dyspnoea and then focuses on discussion of the most frequent causes of chronic and acute dyspnoea in the elderly. The most common causes of dyspnoea in the elderly include heart failure, chronic obstructive pulmonary disease and asthma. Other causes include parenchymal lung disease, pulmonary vascular diseases, upper airway obstruction and pneumonia. Dyspnoea should not be attributed to aging alone. Careful clinical evaluation and spirometry is indicated, and additional testing may be appropriate. In this article, emphasis is placed on the clinical manifestations of dyspnoea in the elderly and an approach to their differential diagnosis is provided. Discussion of available therapy is beyond the scope of this article.
    MeSH term(s) Aged ; Airway Obstruction ; Asthma/physiopathology ; Diagnosis, Differential ; Dyspnea/diagnosis ; Dyspnea/etiology ; Dyspnea/physiopathology ; Heart Failure/complications ; Heart Failure/physiopathology ; Humans ; Lung/anatomy & histology ; Lung/physiology ; Lung Diseases, Obstructive/complications ; Lung Diseases, Obstructive/physiopathology ; Pneumonia/physiopathology ; Pneumothorax/physiopathology ; Pulmonary Embolism/physiopathology
    Language English
    Publishing date 2001-04-09
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 1075770-3
    ISSN 1179-1969 ; 1170-229X
    ISSN (online) 1179-1969
    ISSN 1170-229X
    DOI 10.2165/00002512-200118030-00003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: results of multinational studies.

    Yernault, J C / Russell, D

    International journal of antimicrobial agents

    2008  Volume 2, Issue 1, Page(s) 39–47

    Abstract: The results of two large, multicenter studies comparing the safety and efficacy of lomefloxacin (400 mg administered orally once daily) and amoxicillin (500 mg administered orally three times daily) in adult patients with acute exacerbations of chronic ... ...

    Abstract The results of two large, multicenter studies comparing the safety and efficacy of lomefloxacin (400 mg administered orally once daily) and amoxicillin (500 mg administered orally three times daily) in adult patients with acute exacerbations of chronic bronchitis caused predominantly by Gram-negative pathogens have been combined. The studies were both randomized and blinded. One study enrolled 127 patients in 12 centers in Belgium; the second enrolled 510 patients in 52 centers in ten countries. The protocols were essentially identical, whicl allowed data to be pooled. A total of 253 lomefloxacin-treated patients and 254 amoxicillin-treated patients were considered evaluable. Both groups were well matched in terms of age, gender, and severity of presenting signs and symptoms. The most common pathogens in both treatment groups were Haemophilus influenzae, Pseudomonas aeruginosa, Streptococcus pneumoniae, Moraxella (Branhamella) catarrhalis, and Klebsiella pneumoniae. Two to four days after the conclusion of treatment, bacterial eradication rates were 85.4% for lomefloxacin-treated patients and 75.2% for patients receiving amoxicillin (p = 0.004). The clinical success rate (total of evaluable patients either cured or improved) 2-4 days after the conclusion of treatment for the lomefloxacin group was 90.9%, and for amoxicillin was 82.3% (p = 0.005). The incidence of adverse events was similar in both treatment groups, and no interactions were noted in those patients in both groups who received concomitant theophylline. In these studies, lomefloxacin administered once daily was superior to amoxicillin given three times daily to patients with acute bacterial exacerbations of chronic bronchitis caused predominantly by Gram-negative pathogens.
    Language English
    Publishing date 2008-05-23
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/0924-8579(92)90026-n
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Asthme et BPCO: diagnostic différentiel.

    Yernault, J C

    Revue medicale de Bruxelles

    1999  Volume 20, Issue 4, Page(s) A293–5

    Abstract: Asthma and COPD are common problems seen by general practitioners. They share several signs and symptoms, so that a differential diagnosis generally needs lung function testing, with at least a spirometry, either performed on several occasions, or ... ...

    Title translation Asthma and chronic obstructive bronchopneumopathy: differential diagnosis.
    Abstract Asthma and COPD are common problems seen by general practitioners. They share several signs and symptoms, so that a differential diagnosis generally needs lung function testing, with at least a spirometry, either performed on several occasions, or completed by bronchodilation or non specific bronchoprovocation tests. Spirometry should become one of the tools used daily by a general practitioner.
    MeSH term(s) Adult ; Aged ; Asthma/diagnosis ; Bronchial Provocation Tests ; Diagnosis, Differential ; Forced Expiratory Volume ; Humans ; Lung Diseases, Obstructive/diagnosis ; Maximal Expiratory Flow-Volume Curves ; Maximal Midexpiratory Flow Rate ; Middle Aged ; Respiratory Function Tests ; Spirometry ; Vital Capacity
    Language French
    Publishing date 1999-09
    Publishing country Belgium
    Document type English Abstract ; Journal Article
    ZDB-ID 760217-0
    ISSN 0035-3639
    ISSN 0035-3639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: La toux rebelle.

    Yernault, J C

    Revue medicale de Bruxelles

    1999  Volume 20, Issue 4, Page(s) A305–6

    Abstract: Cough becomes chronic after three weeks of evolution. Chronic cough is due to four syndromes in 90% of cases: postnasal drip syndrome, asthma, gastroesophageal reflux and chronic bronchitis. Each syndrome needs a specific therapeutic approach. ... ...

    Title translation Chronic cough.
    Abstract Cough becomes chronic after three weeks of evolution. Chronic cough is due to four syndromes in 90% of cases: postnasal drip syndrome, asthma, gastroesophageal reflux and chronic bronchitis. Each syndrome needs a specific therapeutic approach. Antitussive drugs like dextromethorphan are prescribed in cases of complicated cough. Cough secondary to angiotensin converting enzyme inhibitors must not be neglected. In case of failure of initial check up or lack of response to specific therapy, a more thorough examination must be conducted in a specialized centre.
    MeSH term(s) Asthma/complications ; Asthma/therapy ; Bronchitis/complications ; Bronchitis/therapy ; Chronic Disease ; Cough/diagnosis ; Cough/etiology ; Cough/therapy ; Diagnosis, Differential ; Gastroesophageal Reflux/complications ; Gastroesophageal Reflux/therapy ; Humans ; Nose Diseases/complications ; Nose Diseases/therapy
    Language French
    Publishing date 1999-09
    Publishing country Belgium
    Document type English Abstract ; Journal Article
    ZDB-ID 760217-0
    ISSN 0035-3639
    ISSN 0035-3639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: L' evidence-based medicine, ou à la recherche de preuves en clinique quotidienne.

    Yernault, J C

    Revue medicale de Bruxelles

    1998  Volume 19, Issue 3, Page(s) 115–117

    Title translation Evidence-based medicine, or evidence research in everyday practice.
    MeSH term(s) Databases as Topic ; Decision Making ; Diagnosis, Differential ; Evidence-Based Medicine ; Humans ; Multicenter Studies as Topic ; Patient Care/standards ; Publishing ; Quality of Health Care ; Randomized Controlled Trials as Topic ; Research Design
    Language French
    Publishing date 1998-06
    Publishing country Belgium
    Document type Editorial
    ZDB-ID 760217-0
    ISSN 0035-3639
    ISSN 0035-3639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The birth and development of the forced expiratory manoeuvre: a tribute to Robert Tiffeneau (1910-1961).

    Yernault, J C

    The European respiratory journal

    1997  Volume 10, Issue 12, Page(s) 2704–2710

    Abstract: The forced expiratory manoeuvre was first described by Tiffeneau and Pinelli working in Paris (France), in December 1947, who proposed measurement of the "pulmonary capacity usable on exercise" (capacité pulmonaire utilisable à l'effort) (CPUE), the ... ...

    Abstract The forced expiratory manoeuvre was first described by Tiffeneau and Pinelli working in Paris (France), in December 1947, who proposed measurement of the "pulmonary capacity usable on exercise" (capacité pulmonaire utilisable à l'effort) (CPUE), the maximal volume expelled in one second after a deep inspiration. It was intended to replace the measurement of the maximum breathing capacity, a difficult and tiring manoeuvre. A similar approach was later followed in the USA by Gaensler, who proposed the "timed vital capacity" in 1951. The name CPUE was changed to "volume expiratoire maximum seconde" (VEMS) by a group of European experts, who met in Paris on February 13, 1954, whereas the expression "forced expiratory volume" was adopted by the British Thoracic Society in 1957. Despite numerous attempts to examine the forced expiration in a different manner, the VEMS and/or forced expiratory volume in one second (FEV1) remain, after 50 yrs the main variables used daily by the respiratory physician. Although primarily a pharmacologist, Robert Tiffeneau (1910-1961) undoubtedly deserves to figure among the pioneers of respiratory medicine.
    MeSH term(s) Forced Expiratory Volume ; France ; History, 20th Century ; Humans ; Pulmonary Medicine/history ; Respiratory Function Tests/history
    Language English
    Publishing date 1997-12
    Publishing country England
    Document type Biography ; Historical Article ; Journal Article
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/09031936.97.10122704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top